Encyclopedia of Metalloproteins

2013 Edition
| Editors: Robert H. Kretsinger, Vladimir N. Uversky, Eugene A. Permyakov

Beryllium as Antigen

Reference work entry
DOI: https://doi.org/10.1007/978-1-4614-1533-6_172



Beryllium exposure can have adverse health effects, starting from the contact allergy to Be and ending with the chronic beryllium disease (CBD) that leads to physiologic impairment and need for immunosuppressive medications, or even with the lung cancer.

Some Physicochemical Properties and Commercial Use

The chemical element beryllium is the fourth element in the chemical periodic table with the symbol of Be, atomic number of 4, and atomic weight of the 9.0122. Beryllium is a typical steel-gray metal, which in its free form exists as a strong, brittle, and lightweight alkaline earth metal. Beryllium is a relatively rare element in both the universe and in the crust of the Earth (it has a concentration of 2–6 parts per million (ppm) in the Earth’s crust), being naturally found only in...

This is a preview of subscription content, log in to check access


  1. Abbas AK, Lichtman AH (2009) Basic Immunology. Functions and disorders of the immune system, 3rd edn. Saunders/Elsevier, PhiladelphiaGoogle Scholar
  2. Boffetta P, Fryzek JP, Mandel JS (2012) Occupational exposure to beryllium and cancer risk: a review of the epidemiologic evidence. Crit Rev Toxicol 42:107–118PubMedCrossRefGoogle Scholar
  3. Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, Marrack P, Kappler JW, Fontenot AP (2010) Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Proc Natl Acad Sci USA 107:7425–7430PubMedCrossRefGoogle Scholar
  4. Emsley J (2001) Nature’s Building blocks: an A-Z guide to the elements. Oxford University Press, OxfordGoogle Scholar
  5. Falta MT, Bowerman NA, Dai S, Kappler JW, Fontenot AP (2010) Linking genetic susceptibility and T cell activation in beryllium-induced disease. Proc Am Thorac Soc 7:126–129PubMedCrossRefGoogle Scholar
  6. Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL (2002) Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest 110:1473–1482PubMedGoogle Scholar
  7. Fontenot AP, Kotzin BL (2003) Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity. Tissue Antigens 62:449–458PubMedCrossRefGoogle Scholar
  8. Henneberger PK, Goe SK, Miller WE, Doney B, Groce DW (2004) Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg 1:648–659PubMedCrossRefGoogle Scholar
  9. Hollins DM, McKinley MA, Williams C, Wiman A, Fillos D, Chapman PS, Madl AK (2009) Beryllium and lung cancer: a weight of evidence evaluation of the toxicological and epidemiological literature. Crit Rev Toxicol 39(Suppl 1):1–32PubMedCrossRefGoogle Scholar
  10. Martin AK, Mack DG, Falta MT, Mroz MM, Newman LS, Maier LA, Fontenot AP (2011) Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression. J Allergy Clin Immunol 128(1100–1106):e1101–e1105Google Scholar
  11. Newman LS, Mroz MM, Balkissoon R, Maier LA (2005) Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 171:54–60PubMedCrossRefGoogle Scholar
  12. Richeldi L, Sorrentino R, Saltini C (1993) HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262:242–244PubMedCrossRefGoogle Scholar
  13. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG (1990) Biased accumulation of T lymphocytes with “memory”-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 171:1123–1140PubMedCrossRefGoogle Scholar
  14. Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG (1989) Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 320:1103–1109PubMedCrossRefGoogle Scholar
  15. Schubauer-Berigan MK, Deddens JA, Couch JR, Petersen MR (2011) Risk of lung cancer associated with quantitative beryllium exposure metrics within an occupational cohort. Occup Environ Med 68:354–360PubMedCrossRefGoogle Scholar
  16. Toledo F, Silvestre JF, Cuesta L, Latorre N, Monteagudo A (2011) Contact allergy to beryllium chloride: report of 12 cases. Contact Dermatitis 64:104–109PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Molecular MedicineUniversity of South Florida, College of MedicineTampaUSA